Abnormal glucose metabolism and pancreatic cancer mortality

JAMA

Volumn 283, Issue 19, 2000, Pages 2552-2558

  Gapstur, Susan M ^a   Gann, Peter H ^a   Lowe, William ^a   Liu, Kiang ^a   Colangelo, Laura ^a   Dyer, Alan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034679058     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.19.2552     Document Type: Article

References (50)

1. American Cancer Society. Cancer Facts and Figures: 1999. Atlanta, Ga: American Cancer Society; 1999.
2. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992;326:455-465.
3. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumani JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, NY: Oxford University Press; 1996:725-771.
4. Noy A, Bilezikian JP. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab. 1994; 79:1223-1231.
5. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 1995;55:2007-2011.
6. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996;63:310-313.
7. Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin North Am. 1998;7:25-41.
8. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women: 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1990; 131:254-262.
9. Smith GD, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol. 1992;136:1110-1114.
10. Stamler J, Stamler R, Rhomberg P, et al. Multivariate analysis of the relationship of six variables to blood pressure: findings from Chicago community surveys, 1965-1971. J Chronic Dis. 1975;28:499-525.
11. Hoffman WS. A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem. 1937;120:51-55.
12. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol. 1997;50:1369-1376.
13. National Center for Health Statistics. International Classification of Diseases (adapted for use in the United States). 8th ed. Washington, DC: US Government Printing Office; 1967.
14. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986;123:504-516.
15. Cooper R, Liu K, Stamler J, et al. Prevalence of diabetes/hyperglycemia and associated cardiovascular risk factors in blacks and whites: Chicago Heart Association Detection Project in Industry. Am Heart J. 1984;108(3 pt 2):827-833.
16. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg. 1993;159: 101-107.
17. Gullo L, Ancona D, Pezzilli R, Casadei R, Campione O. Glucose tolerance and insulin secretion in pancreatic cancer. Ital J Gastroenterol. 1993;25:487-489.
18. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg. 1993;80:1047-1050.
19. Chow WH, Gridley C, Nyren O, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst. 1995; 87:930-931.
20. Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW Jr. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control. 1998;9:403-410.
21. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993;22:30-37.
22. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344-350.
23. Ji BT, Hatch MC, Chow WH, et al. Anthropometrie and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer. 1996;66:432-437.
24. Bueno de Mesquita HB, Moerman CJ, Runia S, Maisonneuve P. Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas? Int J Cancer. 1990;46:435-444.
25. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991;47:1-6.
26. Howe GR, Ghadirian P, Bueno de Mesquita HB, et al. A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer. 1992;51:365-372.
27. Lyon JL, Slattery ML, Mahoney AW, Robison LM. Dietary intake as a risk factor for cancer of the exocrine pancreas. Cancer Epidemiol Biomarkers Prev. 1993;2:513-518.
28. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710-1719.
29. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80:1830-1837.
30. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78: 6858-6862.
31. Takkunen H, Reunanen A, Aromaa A, Knekt P. Raised serum urate concentration as risk factor for premature mortality in middle aged men [letter]. BMJ (Clin Res Ed). 1984;288:1161.
32. Petersson B, Trell E. Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer. BMJ (Clin Res Ed). 1983;287:7-9.
33. Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res. 1988;48: 2916-2918.
34. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989;42:257-267.
35. Criqui MH, Bangdiwala S, Goodman DS, et al. Selenium, retinol, retinol-binding protein, and uric acid: associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol. 1991:1:385-393.
36. Kolonel LN, Yoshizawa C, Nomura AM, Stemmermann CN. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev. 1994;3:225-228.
37. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266:3008-3011.
38. Foster DW. Diabetes mellitus. In: Isselbacher KJ, ed. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill; 1994:1979-2000.
39. Sindelar WF, Kinsella TJ, Mayer RJ. Cancer of the pancreas. In: DeVita VT Jr, Hellman S, Tosenberg SA, eds. Cancer: Principles and Practice of Oncology. 2nd ed. Philadelphia, Pa: JB Lippincott; 1985:691-739.
40. Williams JA, Goldfine ID. The insulin-pancreatic acinar axis. Diabetes. 1985;34:980-986.
41. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center: insulin-like growth factors. N Engl J Med. 1997;336:633-640.
42. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab. 1988;66:266-272.
43. Musey VC, Goldstein S, Farmer PK, Moore PB, Phillips LS. Differential regulation of IGF-1 and IGF-binding protein-1 by dietary composition in humans. Am J Med Sci. 1993;305:131-138.
44. Ohmura E, Okada M, Onoda N, et al. Insulin-like growth factor I and transforming growth factor a as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res. 1990;50:103-107.
45. Vaccaro O, Ruth KJ, Stamler J. Relationship of post-load plasma glucose to mortality with 19-yr follow-up: comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study. Diabetes Care. 1992;15:1328-1334.
46. Liu K, Stamler J, Stamler R, et al. Methodological problems in characterizing an individual's plasma glucose level. J Chronic Dis. 1982;35:475-485.
47. Mollo F, Bertoldo E, Grandi G, Cavallo F. Reliability of death certifications for different types of cancer: an autopsy survey. Pathol Res Pract. 1986;181: 442-447.
48. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101:497-504.
49. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. 2nd ed. Bethesda, Md: National Institutes of Health; 1995:782.
50. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.